Equifax (EFX) Q3 2025 Earnings Transcript

Equifax reported Q3 revenue of $1.54 billion, up over 7%, and adjusted EPS of $2.04, $0.12 above the midpoint of guidance, then raised full-year revenue by $40 million, EPS by $0.12, and free cash flow outlook to $950 million-$975 million. The company highlighted strong mortgage-driven growth, USIS revenue up 11%, EWS up 5%, and International up 7% in constant currency, while also increasing its Vitality Index guidance to 13% and returning $360 million to shareholders. Management also unveiled a $4.50 VantageScore 4.0 mortgage pricing strategy, expanded AI product rollouts, and cited growing government opportunities tied to OB3 legislation.

Analysis

EFX is inflecting from a cyclical data provider into a fee-and-software compounder: the post-cloud operating model is now showing up in both margin structure and product velocity, which matters more than the headline mortgage beat. The key second-order effect is that higher mortgage penetration is being monetized twice—first via mix and pricing, then via downstream share capture as the company bundles employment, identity, and alternative-data attributes into the file. That is structurally better than a one-time volume recovery because it raises the revenue per workflow even if origination volumes stay mediocre.

The Vantage pricing reset is less about near-term score economics and more about breaking a 30-year workflow lock-in. The market is probably underestimating how quickly procurement teams move once the economics become visible, but also overestimating immediate adoption: securitization, reseller plumbing, and lender model governance create a 2-4 quarter lag, so the real earnings torque is 2026-2027, not 4Q25. The larger strategic upside is that every incremental Vantage conversion lowers customer total cost while expanding EFX economics, a rare win-win that can support both share gains and pricing power in adjacent data products.

The government vertical is the underappreciated catalyst. OB3 turns TWN from a nice-to-have verifier into compliance infrastructure, and that changes budget behavior: agencies can justify spend by avoiding downside costs, which is a much stickier sales motion than efficiency alone. The risk is timing, not demand—shutdown-related deferrals and state procurement friction can push revenue recognition rightward, but they do not break the thesis. The bigger bear case is a prolonged mortgage-rate backup or a hiring downturn that compresses Talent, but the company’s free-cash-flow trajectory gives it room to keep buying back stock while waiting for these secular ramps.

Key Decisions for Investors

• Long EFX on pullbacks over the next 2-6 weeks; use a 6-12 month horizon. Risk/reward is attractive because the market is still pricing this as a cyclical data vendor, while 2026-2027 Vantage and OB3 monetization can compound above consensus.
• Pair trade: long EFX / short TRU for 6-12 months. EFX has the cleaner AI + workflow monetization story and a more visible second-half-2026 catalyst stack; TRU is more exposed to slower-pricing, less differentiated credit-file economics.
• Avoid shorting FICO solely on near-term price pressure; instead, use FICO as a relative short only against EFX after any sharp rally. The bear case is real, but the first-order earnings pain can persist longer than anticipated if lenders delay conversion.
• Buy EFX Jan-2027 calls on any post-earnings consolidation. The optionality is in adoption curve acceleration, not the current quarter, and options better capture the asymmetric upside if mortgage workflow conversion turns into a 2026 rerate.
• Set a tactical hedge: if mortgage rates reaccelerate higher or shutdown headlines worsen, trim EFX and rotate into a basket of less cyclical data/software names. The near-term downside is mostly multiple compression, not thesis breakage.